DE:EGQ0 Stock Latest News
Company AnnouncementsINOVIQ Discloses Andrew Chapman’s Securities Interests2h ago
Company AnnouncementsINOVIQ Partners Sonic Healthcare USA to Validate Ovarian Cancer Test5h ago
Company AnnouncementsINOVIQ reshapes board as it refocuses on cancer diagnostics pipeline3d ago
Company AnnouncementsINOVIQ advances EXO-OC ovarian cancer test and CAR-exosome platform amid strategic reset4d ago
Company AnnouncementsInoviq Sets November Date for 2026 Annual General Meeting1w ago
Company AnnouncementsINOVIQ CEO to Step Down as Biotech Charts Next Phase of Growth1w agoCompany AnnouncementsINOVIQ Sets New Pathway for EXO-OC™ After Independent Review Confirms Ovarian Cancer Test Potential1M ago
Company AnnouncementsInoviq Files Appendix 4G, Confirms ASX Governance Compliance2M ago
Company AnnouncementsINOVIQ widens annual loss as revenue falls but asset backing improves2M ago
Company AnnouncementsInoviq updates director interest as listed options expire3M ago
Company AnnouncementsINOVIQ outlines investor risks in EXO-OC cancer test briefing3M ago
Company AnnouncementsINOVIQ Advances Exosome Cancer Programs Despite Setback in Ovarian Test Study3M ago
Company AnnouncementsInoviq Seeks Trading Halt Ahead of Key EXO-OC Clinical Study Results4M ago- Company AnnouncementsInoviq Options Lapse Removes 1.1 Million Potential Shares4M ago
Company AnnouncementsINOVIQ posts strong ovarian cancer data for off-the-shelf CAR-exosome therapy4M ago- Company AnnouncementsInoviq links share price jump to research note as key EXO-OC study nears milestone4M ago
Company AnnouncementsINOVIQ Director Peter Gunzburg Lifts Indirect Shareholding5M agoCompany AnnouncementsInoviq Advances Ovarian Cancer Test and CAR-Exosome Pipeline as Cash Reserves Support Growth6M ago
Company AnnouncementsInoviq Director Max Johnston Increases Indirect Shareholding via On-Market Purchase7M ago